Skip to content

Clinical trials

Prostatic Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Country / region: Netherlands Clear all

245 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20014
20022
20036
20045
20056
20064
20078
20087
200914
201010
20117
20128
20137
201413
20156
201613
20175
201810
20198
202018
202118
202215
202312
202414
202515
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed123
Recruiting38
Active, not recruiting34
Unknown status23
Terminated21
Not yet recruiting3
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Radboud University Medical Center19
AstraZeneca13
The Netherlands Cancer Institute13
Ferring Pharmaceuticals12
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)10
Erasmus Medical Center9
Janssen Research & Development, LLC8
Pfizer8
European Organisation for Research and Treatment of Cancer - EORTC7
GlaxoSmithKline6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms245
Neoplasm Metastasis17
Neoplasms17
Breast Neoplasms10
Lung Neoplasms8
Urinary Bladder Neoplasms7
Head and Neck Neoplasms6
Ovarian Neoplasms6
Pancreatic Neoplasms6
Colorectal Neoplasms5

Trials

Showing 1 to 25 of 245. Each trial links to its page on Pharma Observatory.

145 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.